Effects of indoramin in rat vas deferens and aorta: concomitant alpha1-adrenoceptor and neuronal uptake blockade
- PMID: 10482913
- PMCID: PMC1566180
- DOI: 10.1038/sj.bjp.0702735
Effects of indoramin in rat vas deferens and aorta: concomitant alpha1-adrenoceptor and neuronal uptake blockade
Abstract
1. The actions of the alpha1-adrenoceptor antagonist indoramin have been examined against the contractions induced by noradrenaline in the rat vas deferens and aorta taking into account a putative neuronal uptake blocking activity of this antagonist which could result in self-cancelling actions. 2. Indoramin behaved as a simple competitive antagonist of the contractions induced by noradrenaline in the vas deferens and aorta yielding pA2 values of 7.38+/-0.05 (slope=0.98+/-0.03) and 6.78+/-0.14 (slope=1.08+/-0.06), respectively. 3. When the experiments were repeated in the presence of cocaine (6 microM) the potency (pA2) of indoramin in antagonizing the contractions of the vas deferens to noradrenaline was increased to 8.72+/-0.07 (slope=1.10+/-0.05) while its potency remained unchanged in the aorta (pA2=6.69+/-0.12; slope=1.04+/-0.05). 4. In denervated vas deferens, indoramin antagonized the contractions to noradrenaline with a potency similar to that found in the presence of cocaine (8.79+/-0.07; slope=1.09+/-0.06). 5. It is suggested that indoramin blocks alpha1-adrenoceptors and neuronal uptake in rat vas deferens resulting in Schild plots with slopes not different from unity even in the absence of selective inhibition of neuronal uptake. As a major consequence of this double mechanism of action, the pA2 values for this antagonist are underestimated when calculated in situations where the neuronal uptake is active, yielding spurious pKB values.
Figures


Similar articles
-
Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.Br J Pharmacol. 1995 Jun;115(3):467-75. doi: 10.1111/j.1476-5381.1995.tb16356.x. Br J Pharmacol. 1995. PMID: 7582458 Free PMC article.
-
Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.Br J Pharmacol. 1997 Nov;122(5):849-58. doi: 10.1038/sj.bjp.0701461. Br J Pharmacol. 1997. PMID: 9384500 Free PMC article.
-
Effect of cyproterone acetate on alpha1-adrenoceptor subtypes in rat vas deferens.Braz J Med Biol Res. 2003 Nov;36(11):1571-81. doi: 10.1590/s0100-879x2003001100015. Epub 2003 Oct 22. Braz J Med Biol Res. 2003. PMID: 14576912
-
Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.Auton Autacoid Pharmacol. 2013 Oct;33(3-4):49-57. doi: 10.1111/aap.12015. Epub 2013 Sep 18. Auton Autacoid Pharmacol. 2013. PMID: 24074250
-
Functional effects of castration on alpha1-adrenoceptors in rat vas deferens.Eur J Pharmacol. 1998 Jun 19;351(2):217-23. doi: 10.1016/s0014-2999(98)00315-x. Eur J Pharmacol. 1998. PMID: 9687006
Cited by
-
Selective release of ATP from sympathetic nerves of rat vas deferens by the toxin TsTX-I from Brazilian scorpion Tityus serrulatus.Br J Pharmacol. 2005 Feb;144(4):519-27. doi: 10.1038/sj.bjp.0706062. Br J Pharmacol. 2005. PMID: 15678093 Free PMC article.
-
Functional characterisation of alpha(1)-adrenoceptors in denervated rat vas deferens.Naunyn Schmiedebergs Arch Pharmacol. 2003 Jul;368(1):72-8. doi: 10.1007/s00210-003-0770-z. Epub 2003 Jul 5. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12845422
References
-
- BLACK J.L., MYLECHARANE E.J. Actions of indoramin on rabbit and human vasculature. Clin. Exp. Pharmacol. Physiol. 1984;11:27–35. - PubMed
-
- CUBEDDU L.X. New alpha1-adrenergic receptor antagonists for the treatment of hypertension: Role of vascular alpha receptors in control of peripheral resistance. Am. Heart. J. 1988;116:133–162. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous